Article
Development of multivalent Nanobodies blocking SARS-CoV-2 infection by targeting RBD of…
Research square · 2020 · Qizhong Lu, author Zongliang Zhang, author Hexian Li, author Kunhong Zhong, author Qin Zhao, author Zeng Wang, author Zhiguo Wu, author Donghui Yang, author Shuang Sun, author Nian Yang, author Meijun Zheng, author Shasha Zhao, author Cheng Long, author Wenhao Guo, author Hui Yang, author Chunlai Nie, author Aiping Tong, author
Key facts
| Title | Development of multivalent Nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein |
|---|---|
| First author | Qizhong Lu, author Zongliang Zhang, author Hexian Li, author Kunhong Zhong, author Qin Zhao, author Zeng Wang, author Zhiguo Wu, author Donghui Yang, author Shuang Sun, author Nian Yang, author Meijun Zheng, author Shasha Zhao, author Cheng Long, author Wenhao Guo, author Hui Yang, author Chunlai Nie, author Aiping Tong, author |
| Journal | Research square |
| Published | Nov 18, 2020 |
| DOI | 10.21203/rs.3.rs-105739/v1 |
| Devices mentioned | K042152, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, KDT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1